Anal cytological lesions and HPV infection in individuals at increased risk for anal cancer

Cancer Cytopathol. 2018 Jul;126(7):461-470. doi: 10.1002/cncy.22003. Epub 2018 Apr 25.

Abstract

Background: Anal cytology may be useful for evaluating lesions associated with human papillomavirus (HPV) in individuals at increased risk for anal cancer.

Methods: Liquid-based cytology was used to assess anal cytological lesions among human immunodeficiency virus (HIV)-infected and HIV-uninfected men who have sex with men (MSM). The Linear Array HPV genotyping test was used for HPV detection.

Results: This cross-sectional study included 1021 MSM, of whom 388 were HIV-infected (38.0%). Anal cytological lesions (atypical squamous cells of undetermined significance or more severe [ASCUS+]) were observed in 32.5% and 53.2% of the HIV-uninfected and HIV-infected individuals, respectively (P < .0001). The highest ASCUS + prevalence was observed among ≥45-year-old HIV-uninfected MSM (37.3%) and 25-to 29-year-old HIV-infected MSM (66.7%). High-grade squamous intraepithelial lesions (HSILs) peaked in ≥ 45-year-old HIV-uninfected subjects and 35- to 39-year-old HIV-infected subjects. Individuals with anal infections with high-risk (HR) HPV types were 3 to 4 times more likely to have an ASCUS + report. An HPV-16 and/or HPV-18 infection increased the odds of HSIL or more severe cytology (HSIL+) for HIV-infected MSM almost 4 times. MSM concurrently infected with HR and low-risk HPVs were significantly more likely to have low-grade squamous intraepithelial lesions or more severe cytology (LSIL+) than those infected with only HR types. No significant associations were found between cytological abnormalities and the HIV load and nadir and current CD4 + counts.

Conclusions: The prevalence of anal cytological lesions is high in MSM, even in HIV-infected individuals treated with combined antiretroviral therapy. In these subjects, HSILs occur more frequently and at a younger age in comparison with HIV-uninfected counterparts. Specific diagnostic procedures should be implemented to manage individuals at increased risk for anal cancer with an abnormal anal Papanicolaou test. Cancer Cytopathol 2018. © 2018 American Cancer Society.

Keywords: anal Papanicolaou (Pap) test; anal cancer; anal cytology; anal neoplasia; human immunodeficiency virus (HIV); human papillomavirus; men who have sex with men; sexually transmitted infection (STI).

MeSH terms

  • Adolescent
  • Adult
  • Anus Neoplasms / diagnosis*
  • Anus Neoplasms / epidemiology
  • Anus Neoplasms / virology
  • Biomarkers / analysis*
  • Carcinoma, Squamous Cell / diagnosis*
  • Carcinoma, Squamous Cell / epidemiology
  • Carcinoma, Squamous Cell / virology
  • Cross-Sectional Studies
  • Cytodiagnosis / methods*
  • Early Detection of Cancer*
  • Homosexuality, Male / statistics & numerical data*
  • Humans
  • Incidence
  • Italy / epidemiology
  • Male
  • Middle Aged
  • Papillomaviridae / isolation & purification
  • Papillomavirus Infections / complications*
  • Papillomavirus Infections / pathology
  • Prognosis
  • Risk Factors
  • Young Adult

Substances

  • Biomarkers